Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Diabetes Obes Metab ; 18(11): 1147-1151, 2016 11.
Article in English | MEDLINE | ID: mdl-27350651

ABSTRACT

Recently, glucagon-like peptide-1 (GLP-1) levels have been found to be increased in response to inflammatory stimuli, leading to insulin secretion and prevention of hyperglycaemia during endotoxemia in mice. In the present study, we assess the relevance of the other incretin hormone, glucose-dependent insulinotropic peptide (GIP), as a regulator of glucose metabolism under inflammatory conditions. We found that lipopolysaccharide (LPS) increased GIP secretion in a time- and dose-dependent manner in C57BL/6J mice. To elucidate the underlying mechanisms, mice were injected with inflammatory cytokines known to be released by LPS. Circulating GIP levels significantly increased in response to interleukin (IL)-1ß but not IL-6 or tumour necrosis factor (TNF)-α administration. Using respective knockout mice we found that LPS-mediated GIP secretion was selectively dependent on IL-1 signalling. To evaluate the functional relevance of inflammatory GIP secretion we pretreated mice with the GIP-receptor antagonist (Pro3)GIP. This blunted LPS-induced TNF-α and IL-6 secretion but did not affect LPS-induced insulin secretion or blood glucose-lowering. In conclusion, GIP provides a novel link between the immune system and the gut, with proinflammatory-immune modulatory function but minor glucose regulatory relevance in the context of acute endotoxemia.


Subject(s)
Blood Glucose/metabolism , Gastric Inhibitory Polypeptide/metabolism , Inflammation/chemically induced , Interleukin-1beta/physiology , Lipopolysaccharides/pharmacology , Receptors, Interleukin-1 Type I/physiology , Animals , Blood Glucose/drug effects , Inflammation/metabolism , Interleukin-6/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Receptors, Interleukin-1 Type I/genetics , Up-Regulation/drug effects
3.
Sci Rep ; 5: 9023, 2015 Mar 17.
Article in English | MEDLINE | ID: mdl-25777360

ABSTRACT

Atherosclerosis is a chronic inflammatory disease characterized by the infiltration of pro-inflammatory macrophages into a lipid-laden plaque. ITCH is an E3 ubiquitin ligase that has been shown to polarize macrophages to an anti-inflammatory phenotype. We therefore investigated the effect of ITCH deficiency on the development of atherosclerosis. ApoE-/-ITCH-/- mice fed a western diet for 12 weeks showed increased circulating M2 macrophages together with a reduction in plaque formation. Bone marrow transplantation recreated the haemopoietic phenotype of increased circulating M2 macrophages but failed to affect plaque development. Intriguingly, the loss of ITCH lead to a reduction in circulating cholesterol levels through interference with nuclear SREBP2 clearance. This resulted in increased LDL reuptake through upregulation of LDL receptor expression. Furthermore, ApoE-/-ITCH-/- mice exhibit reduced hepatic steatosis, increased mitochondrial oxidative capacity and an increased reliance on fatty acids as energy source. We found that ITCH ubiquitinates SIRT6, leading to its breakdown, and thus promoting hepatic lipid infiltration through reduced fatty acid oxidation. The E3 Ubiquitin Ligase ITCH modulates lipid metabolism impacting on atherosclerosis progression independently from effects on myeloid cells polarization through control of SIRT6 and SREBP2 ubiquitination. Thus, modulation of ITCH may provide a target for the treatment of hypercholesterolemia and hyperlipidemia.


Subject(s)
Apolipoproteins E/deficiency , Atherosclerosis/genetics , Atherosclerosis/metabolism , Lipid Metabolism , Sirtuins/metabolism , Sterol Regulatory Element Binding Protein 2/metabolism , Ubiquitin-Protein Ligases/metabolism , Animals , Atherosclerosis/immunology , Atherosclerosis/pathology , Bone Marrow Transplantation , Cholesterol/blood , Cholesterol/metabolism , Disease Models, Animal , Fatty Liver/metabolism , Fatty Liver/pathology , Inflammation/genetics , Inflammation/metabolism , Liver/metabolism , Macrophages/metabolism , Mice , Mice, Knockout , Mitochondria/metabolism , Oxidation-Reduction , Ubiquitination
SELECTION OF CITATIONS
SEARCH DETAIL
...